Meeting highlights from the Committee for Medicinal Products…
Five new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended five medicines for approval at its March 2022 meeting. The monoclonal antibody Evusheld (tixagevimab / cilgavimab) received a positive opinion from the CHMP for the prevention of COVID-19. More details are available in a separate news announcement. A new gene therapy, Carvykti* (ciltacabtagene […]
